EUVIMEDEUVIMED entdecken
Crossref

Dual Single‐Atom Engineered NADH Oxidase‐Mimic Boosts In Situ NAD + Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection

Jingtao Liu iD, Xun Guo, Nan Wang, Xingyu Zhang, Xiaoting Wang, Guangru Li, Xumin Hou, Luodan Yu, Yu Chen iD, Ruogu Li

Advanced Materials · 2026

DOI: 10.1002/adma.202519122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Jingtao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, China. Hauptthemen laut MEDLINE: NAD, Myocardial Reperfusion Injury, NADH, NADPH Oxidoreductases, Multienzyme Complexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Institutional Animal Care and Use Committee at the Shanghai Chest Hospital, National Natural Science Foundation of China, China National Postdoctoral Program for Innovative Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia/reperfusion (I/R) injury is a globally recognized pathological condition that results in life‐threatening organ dysfunction. Supplementation with nicotinamide adenine dinucleotide (NAD + ) can improve myocardial energy metabolism, alleviate inflammation, and mitigate I/R injury. However, its clinical applicability is constrained by the poor efficacy and delivery limitations of current NAD + supplementation strategies. Here, we design a dual single‐atom nanozyme with nicotinamide adenine dinucleotide (NADH) oxidase‐mimicking activity for in situ NAD + biotransformation and I/R injury treatment. Upon M2 macrophage membrane coating, the nanozyme selectively targets ischemic myocardium, facilitating in situ NAD + biotransformation by eliminating excess NADH, while concurrently scavenging reactive oxygen species, restoring mitochondrial bioenergetics, attenuating inflammation, and inhibiting apoptosis. Mechanistic investigations demonstrate that the nanozyme activates the NAD + ‐SIRT1 axis, enhancing ATP biosynthesis and oxidative phosphorylation, while suppressing TNF signaling and NF‐κB pathways. Collectively, the engineered NOX‐like nanozyme offers a novel therapeutic strategy for myocardial I/R injury by modulating both mitochondrial bioenergetics and oxidative stress defense pathways through restoring NAD + /NADH homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NADMyocardial Reperfusion InjuryNADH, NADPH OxidoreductasesMultienzyme ComplexesBiomimetic MaterialsAnimalsBiotransformationMiceReactive Oxygen SpeciesMitochondriaEnergy Metabolism

Stichwörter der Autor:innen

NADH oxidasedual single‐atom nanozymein situ NAD+ biotransformationmitochondrial bioenergeticsmyocardial ischemia/reperfusion

Substanzen

NADNADH, NADPH OxidoreductasesNADH oxidaseMultienzyme ComplexesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, China.
  • Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing, P. R. China.
  • Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing, P. R. China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, P. R. China.
  • Department of Radiology, Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.

ORCID-Profile: Jingtao Liu, Yu Chen

Förderung

  • Institutional Animal Care and Use Committee at the Shanghai Chest Hospital
  • National Natural Science Foundation of China
  • China National Postdoctoral Program for Innovative Talents

Zitieren

APA

Liu, J., Guo, X., Wang, N., Zhang, X., Wang, X., Li, G., Hou, X., Yu, L., Chen, Y., & Li, R. (2026). Dual Single‐Atom Engineered NADH Oxidase‐Mimic Boosts In Situ NAD + Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection. Advanced Materials. https://doi.org/10.1002/adma.202519122

Vancouver

Liu J, Guo X, Wang N, Zhang X, Wang X, Li G, et al. Dual Single‐Atom Engineered NADH Oxidase‐Mimic Boosts In Situ NAD + Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection. Advanced Materials. 2026. doi:10.1002/adma.202519122

BibTeX
@article{Liu2026,
  author = {Liu, Jingtao and Guo, Xun and Wang, Nan and Zhang, Xingyu and Wang, Xiaoting and Li, Guangru and Hou, Xumin and Yu, Luodan and Chen, Yu and Li, Ruogu},
  title = {Dual Single‐Atom Engineered NADH Oxidase‐Mimic Boosts In Situ NAD + Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202519122}
}
Kostenlos starten →